Cellectis Net Receivables from 2010 to 2025

CLLS Stock  USD 1.85  0.02  1.09%   
Cellectis Net Receivables yearly trend continues to be comparatively stable with very little volatility. Net Receivables will likely drop to about 15.9 M in 2025. From the period from 2010 to 2025, Cellectis Net Receivables quarterly data regression had r-value of  0.40 and coefficient of variation of  48.09. View All Fundamentals
 
Net Receivables  
First Reported
2008-12-31
Previous Quarter
23 M
Current Value
25.5 M
Quarterly Volatility
8.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cellectis financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cellectis' main balance sheet or income statement drivers, such as Depreciation And Amortization of 20.9 M, Interest Expense of 7.8 M or Selling General Administrative of 29.7 M, as well as many indicators such as Price To Sales Ratio of 3.47, Dividend Yield of 0.0 or PTB Ratio of 1.1. Cellectis financial statements analysis is a perfect complement when working with Cellectis Valuation or Volatility modules.
  
Build AI portfolio with Cellectis Stock
Check out the analysis of Cellectis Correlation against competitors.

Latest Cellectis' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Cellectis SA over the last few years. It is Cellectis' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cellectis' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Cellectis Net Receivables Regression Statistics

Arithmetic Mean15,880,867
Geometric Mean13,186,151
Coefficient Of Variation48.09
Mean Deviation5,407,121
Median16,549,318
Standard Deviation7,637,084
Sample Variance58.3T
Range28.3M
R-Value0.40
Mean Square Error52.5T
R-Squared0.16
Significance0.12
Slope642,316
Total Sum of Squares874.9T

Cellectis Net Receivables History

202515.9 M
202423 M
202323.1 M
202217.6 M
202131.1 M
202019.2 M
201915.3 M

About Cellectis Financial Statements

Cellectis shareholders use historical fundamental indicators, such as Net Receivables, to determine how well the company is positioned to perform in the future. Although Cellectis investors may analyze each financial statement separately, they are all interrelated. The changes in Cellectis' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cellectis' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Net Receivables23 M15.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.